Esomeprazole Capsule, Delayed Release
NDC Package 57896-740-42

11-digit billing NDC: 57896074042
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Esomeprazole (esomeprazole magnesium) capsules is adults 18 years of age and olderthis product is to be used once a day (every 24 hours), every day for 14 daysmay take 1 to 4 days for full effect 14-Day Course of Treatmentswallow 1 capsule with a glass of water before eating in the morningtake every day for 14 daysdo not take more than 1 capsule a dayswallow whole. This formulation utilizes a capsule, delayed release delivery system. Marketed by Geri-care Pharmaceuticals, Corp, this product is identified by NDC 57896-740 and is authorized under FDA application ANDA212866.

Identification & Billing

NDC Package Code
57896-740-42
Package Description
3 BOTTLE in 1 CARTON / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE (57896-740-14)
Product Code
57896-740
11-Digit Billing Format
57896074042
RxNorm Crosswalk
  • RxCUI: 606726 - esomeprazole magnesium 20 MG Delayed Release Oral Capsule
  • RxCUI: 606726 - esomeprazole 20 MG Delayed Release Oral Capsule
  • RxCUI: 606726 - esomeprazole 20 MG (as esomeprazole magnesium dihydrate 22 MG) Delayed Release Oral Capsule
  • RxCUI: 606726 - esomeprazole 20 MG (as esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Capsule

Clinical Specifications

Proprietary Name
Esomeprazole
Non-Proprietary Name
Esomeprazole Magnesium
Substance Name
Esomeprazole Magnesium
Dosage Form
Capsule, Delayed Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ESOMEPRAZOLE MAGNESIUM 20 mg/1
Pharmacologic Class
Usage Information
Adults 18 years of age and olderthis product is to be used once a day (every 24 hours), every day for 14 daysmay take 1 to 4 days for full effect 14-Day Course of Treatmentswallow 1 capsule with a glass of water before eating in the morningtake every day for 14 daysdo not take more than 1 capsule a dayswallow whole. Do not crush or chew capsules.do not use for more than 14 days unless directed by your doctorRepeated 14-Day Courses (if needed)you may repeat a 14-day course every 4 monthsdo not take for more than 14 days or more often than every 4 months unless directed by a doctorchildren under 18 years of age: ask a doctor before use. Heartburn in children may sometimes be caused by a serious condition.

Regulatory & Marketing

Labeler Name
Geri-care Pharmaceuticals, Corp
Product Type
Human Otc Drug
FDA Application #
ANDA212866
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-19-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57896-740-42 identifies a specific commercial package of 3 bottle in 1 carton / 14 capsule, delayed release in 1 bottle (57896-740-14) of Esomeprazole, a human over the counter drug labeled by Geri-care Pharmaceuticals, Corp. This capsule, delayed release is formulated for oral use and contains esomeprazole magnesium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Geri-care Pharmaceuticals, Corp on August 19, 2026. The current certification is valid through December 31, 2027.

How is this Geri-care Pharmaceuticals, Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57896074042. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
57896-740-42
11-Digit CMS (5-4-2)
57896-0740-42

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.